MedTrace Logo

Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamic

NCT02374775 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2017-04-04

No results posted yet for this study

Summary

The EMERALD trial is a multinational, multicenter study. The patients presented with AMI/definite evidence of plaque rupture and had underwent coronary CT angiography from 1 month to 2 year prior to the event will be retrospectively searched. Plaques in the non-culprit vessels will be regarded as internal control to the ruptured plaque in the culprit vessel.

Conditions

Sponsors & Collaborators

  • HeartFlow, Inc.

    collaborator INDUSTRY

  • Kyoto University, Graduate School of Medicine

    collaborator OTHER

  • Inje University

    collaborator OTHER

  • Keimyung University Dongsan Medical Center

    collaborator OTHER

  • Ulsan University Hospital

    collaborator OTHER

  • Wakayama Medical University

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Bon-Kwon Koo, MD, PhD · Seoul National University Hospital

  • Bon-Kwon Koo, MD, PhD · Seoul National University Hospital

  • Joo Myung Lee, MD, MPH · Samsung Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-09-30
Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02374775 on ClinicalTrials.gov